hAPRIL-01-A

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamehAPRIL-01-A
Drug Alias NamehAPRIL-01-AhAPRIL.01AhAPRIL-01A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitors
TargetsTumor necrosis factor ligand superfamily member 13
Therapy Area/IndicationsLeukemia, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcademic Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcademic Medical Center
Active IndicationsN/A
Inactive IndicationsLeukemia, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A